Facebook
Instagram
Linkedin
Soundcloud
Twitter
Youtube
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
A PROJECT OF THE INDEPENDENT INSTITUTE
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Home
Blog
Page 2
Blog
Blog
Insulin Price-Caps: A Solution or a Recipe for Rationing?
Raymond March
-
March 31, 2023
0
Blog
When is a Drug Safe and Effective Enough?
Raymond March
-
March 3, 2023
0
Blog
The FDA is Too Little Too Late in Tinkering with Covid-19 Booster Schedules
Raymond March
-
February 23, 2023
0
Blog
Deregulation Remains Our Best Hope to Combat Alzheimer’s Disease
Raymond March
-
February 17, 2023
0
Blog
Here Is How the FDA Made the RSV Wave More Dangerous
Raymond March
-
December 6, 2022
0
Blog
Why Does Dr. Fauci’s Replacement Matter So Much?
Raymond March
-
November 30, 2022
0
Blog
Mental Health Is in Crisis. What Is the Answer?
Raymond March
-
November 25, 2022
0
Blog
Three More Months of the Ratchet Effect?
Raymond March
-
October 31, 2022
0
Blog
Don’t Let the FDA Tell You What’s Healthy
Raymond March
-
October 20, 2022
0
Blog
Why Did it Take So Long for the US to Get the Novavax Vaccine?
Raymond March
-
August 12, 2022
0
1
2
3
...
13
Page 2 of 13